ArticleCardiovascular and interventional radiology2025
Impact of Thyroid Arterial Embolization on Clinical and Biochemical Outcomes and Quality of Life in Patients with Nodular and Multinodular Goiter.
Article in Cardiovascular and interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The gland that never descended: Preoperative transarterial embolization of a symptomatic lingual thyroid.Radiology case reports · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess the safety and efficacy of thyroid arterial embolization (TAE) and its impact on clinical outcomes and quality of life (QoL) in patients with nodular and multinodular goiter (NG/ MNG). MATERIALS AND
methodsThe study included 20 patients with NG/ MNG (16 women, 4 men; mean age, 37 years) who underwent TAE using polyvinyl alcohol (PVA) particles (350-500 μm) between January 2022 and December 2023. Clinical, radiological and quality of life (QoL) assessment (thyPRO-39 questionnaire) were performed at baseline and 6 months post-procedure. Biochemical evaluation with thyroid function tests were done at 1 week, 1 month, 3 months and 6 months post-procedure.
resultsOf 20 patients, 16 had solitary thyroid nodules (STN), while 4 had multinodular goiter (MNG). Three patients had non-Graves hyperthyroidism, while the remainder were euthyroid. Technical success was achieved in all patients. 35 out of 82 interrogated thyroid arteries were seen supplying the nodules and were successfully embolized using PVA particles. At 6 months follow-up, no major complications were reported. Minor complications, including neck pain (60%), fever (20%), toothache (5%) and arm pain (5%) were seen and responded well to conservative management. The median volume of STN/dominant nodule decreased by 63.7%, from 27.5 ml (13.7-59) to 10 ml (7-17.0) (p < 0.001). Goiter score decreased from 40 (34-78.5) to 17.5 (12.5-31.5), hyperthyroid score from 15.5 (10.5-38.5) to 8 (2-13), cosmetic/ appearance score from 43 (28-51) to 1 (1-21), composite score from 26.1 (21.5-40.9) to 17.6 (14.7-26.1), and QoL score from 25 (25-50) to 0 (0-25); all changes were statistically significant (p < 0.001).
conclusionTAE is a safe and effective treatment option in the non-surgical management of benign NG/ MNG, significantly improving these patients' clinical outcome and having a favourable impact on quality of life.
Indexed as
Identifiers
40481311What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.